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ABSTRACT
Primary ovarian pregnancy is a rare type of ectopic preg-
nancy, particularly following in vitro fertilization. Al-
though there have been a few reported cases of primary
ovarian pregnancy following in vitro fertilization embryo
transfer, we believe this is the first report involving donor
embryo transfer. A high index of clinical suspicion, abnor-
mal human chorionic gonadotropin levels, and early ul-
trasound evaluation may aid timely diagnosis and appro-
priate management. This report provides a reminder to
practitioners to advise patients undergoing embryo trans-
fer of the primary ovarian pregnancy risk. Information is
provided herein regarding the diagnosis and management
of primary ovarian pregnancy in women treated with in
vitro fertilization. We review the criteria for early diagnosis
and treatment options.
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INTRODUCTION
Primary ovarian pregnancy (POP) is a rare form of ectopic
implantation. The incidence of natural POP ranges from
1:60 000 to 1:1 500 deliveries, accounting for 3.3% of all
ectopic pregnancies.1 Since the report of the first success-
ful human in vitro fertilization embryo transfer (IVF-ET)
cycle resulting in ectopic pregnancy, the association of
ectopic pregnancy and IVF cycles has been well estab-
lished. Despite the increased incidence of ectopic preg-
nancy associated with assisted reproductive technologies,
POP is still a rare phenomenon. Following IVF-ET cycles,
the overall prevalence of ovarian pregnancy has been
estimated at 0.3%, representing 6% of all ectopic pregnan-
cies.2 With new technologies being introduced for IVF-ET
in recent years, POP has been reported after some of these
procedures. Thus, 3 reports highlight POP occurrence
after intracytoplasmic sperm injection (ICSI) and blasto-
cyst transfer.3,4 Donor embryo transfer is a relatively new
procedure and, to our knowledge, has not been reported
in association with ovarian pregnancy.
We report a case of POP that occurred after early donor
embryo transfer in a woman with no predisposing factors
for ectopic implantation. This case is unique because the
ovarian implantation occurred after ovarian suppression
rather than with hyperstimulation, retrieval, and formation
of corpora lutea cysts as reported in prior published case
reports.
CASE REPORT
A 39-year-old nulligravid woman presented to our fertility
center for evaluation of primary infertility. On initial ex-
amination, a transverse vaginal septum obscuring the cer-
vix and a 1.5-cm subserosal fibroid were identified. The
vaginal septum was resected. Further assessment with
hysteroscopy and hysterosalpingography revealed a nor-
mal uterine cavity and tubal anatomy.
The husband was diagnosed with azoospermia and had
twice undergone testicular biopsy with insufficient sper-
matogenesis, preventing sperm retrieval. The couple was
offered intrauterine insemination or IVF-ET with donor
sperm. However, these options were declined because of
religious beliefs. They elected and arranged for a donor
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CASE REPORTembryo transfer at a fertility center in their home country.
The patient then had an ovarian suppression with a long
protocol using Buserelin acetate and estradiol valerate.
Five donor embryos were transferred with one embryo at
2-cell stage. Micronized progesterone and estradiol were
initiated following the transfer.
The patient returned to our fertility center for further care.
Human chorionic gonadotropin (HCG) levels were fol-
lowed. The initial value was only 5 IU/L on posttransfer
day 14 with an increase to 11, 27, 47 and 653 IU/L on days
16, 18, 20 and 27, respectively (Figure 1). Ultrasound
evaluation on day 27 showed no intrauterine gestation
and normal adnexae. A repeat ultrasound was performed
8 days later after the patient experienced vaginal spotting
with rising HCG. Normal adnexa and a clot in the uterus
were found. On day 40, the HCG level reached 4811 IU/L.
At that time, an ultrasonogram was significant for a 1.5 cm
x 1.5 cm x 1.4 cm solid echogenic structure with rein-
forced vascular marking within to the left ovary suggesting
primary ovarian pregnancy (Figure 2). Our patient
elected surgical management. An operative laparoscopy
was performed on day 41 after transfer. Intraoperatively,
the uterus and both fallopian tubes appeared normal. The
left ovary was enlarged by a 3.0 cm x 2.0 cm heteroge-
neous mass consisting of several hemorrhagic bluish
cysts, with a smooth external surface (Figure 3). This
mass was carefully dissected using bipolar cautery and
scissors. The intact ovarian pregnancy was removed
through the umbilical incision by using an endobag. In-
traoperative frozen section and final histology confirmed
the presence of the conception products associated with
ovarian tissue. The right ovary was of normal size and
color. A small amount of serous fluid was in the posterior
cul-de-sac. Uterine curettage showed proliferative endo-
metrium free of chorionic villi. Intraoperative blood loss
was minimal. The patient had an uneventful postoperative
recovery and was discharged the same day. Follow-up
quantitative HCG levels declined appropriately and
reached an undetectable level (2 IU/L) 19 days after
surgery (Figure 1).
DISCUSSION
Although a rare phenomenon, primary ovarian pregnancy
is an important complication associated with IVF-ET treat-
ment. Little is known about its true incidence or risk
factors. Theoretical risk factors for ovarian implantation
Figure 1. Course of HCG level plotted against the number of days after embryo transfer.
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progesterone levels from multiple corpus lutea, ovarian
hypervascularity after hyperstimulation and egg retrieval,
excessive endometrial cavity distension with media during
embryo transfer, a high number of the transferred em-
bryos, and transfer of blastocyst.2–6 In contrast, the donor
embryo IVF cycle requires ovarian suppression, eliminat-
ing most hypothesized risk factors. However, in our case,
a high number of transferred embryos is a possible expla-
nation of ovarian implantation. Interestingly, the most
frequently reported site of ovarian pregnancy is the left
ovary, leaving the question of exact mechanism of retro-
grade embryo migration open.
1,3–4,7
Because the occurrence of ovarian pregnancy is difficult
to predict, its early recognition is imperative in patients
undergoing IVF treatment. In fact, up to 50% of primary
ovarian pregnancies might be diagnosed at an asymptom-
atic state mainly based on a physician’s suspicion and
experience,2 preventing serious complications such as
massive hemoperitoneum.3 The variability of clinical signs
and symptoms might be initially misleading.3,8,9 Although
not specific for ovarian pregnancy, abnormally low- and
slow-rising HCG levels aid in early recognition of abnor-
mal implantation.2 Early use of ultrasonography in IVF
programs has improved diagnosis of ovarian pregnancy.6
The initial sonographic picture of ovarian pregnancy
might be obscured by multiple corpora lutea cysts after
Figure 2. Transvaginal ultrasound on day 40 post embryo transfer: echogenic structure with reinforced vascular marking within the left
ovary.
Figure 3. Photograph of the left ovary with the ovarian preg-
nancy (OP) at laparoscopy.
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cycle.7 The decisive ultrasonographic characteristics are
the visualization of gestational sac structures and the pres-
ence of fetal heart beat within the ovary.1 However, even
the subtle sonographic findings, such as a round echo-
genic mass with reinforced vascular marking within the
ovary and free peritoneal fluid, are consistent with ovarian
pregnancy in case of ovarian suppression for donor em-
bryo transfer (Figure 2).
Laparoscopic management with resection of ovarian ges-
tation and preservation of remaining ovarian tissue is the
preferred treatment for ovarian pregnancy.1–2,4,9 To avoid
misdiagnosis, surgical frozen section at the time of surgery
is advisable, especially when the picture of primary ovar-
ian pregnancy is not clear.10 Additionally, successful med-
ical management with methotrexate as an alternative to
surgery and treatment for a persistent trophoblast after
laparoscopic resection of ovarian gestation has been re-
ported.10 However, the absence of a histopathological
diagnosis needed to meet the widely accepted Spiegel-
berg’s criteria of primary ovarian pregnancy11 precludes
using methotrexate as the first line of treatment.
CONCLUSION
It is important for clinicians and patients to recognize the
possibility of developing a primary ovarian pregnancy
after ovarian suppression and donor embryo transfer in an
IVF program. Our case demonstrates that close follow-up
of abnormally rising HCG, clinical suspicion, and sono-
graphic appearance of an adnexal mass can lead to the
early diagnosis and successful laparoscopic ovary preserv-
ing treatment.
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